<!-- SPDX-License-Identifier: CC-BY-4.0 -->
<!-- Copyright Contributors to the ODPi Egeria project. -->

# Coco Pharmaceutical Scenarios

The scenarios follow the [Coco Pharmaceutical personas](/practices/coco-pharmaceuticals/personas/overview) as they work to
set up their new roles and meet the challenges their new responsibilities bring.

* [Defining the data strategy](/practices/coco-pharmaceuticals/scenarios/defining-the-data-strategy/overview)
   
    - [Planning for common data definitions](/practices/coco-pharmaceuticals/scenarios/planning-for-common-data-definitions/overview)
    - [Identifying authoritative sources](/practices/coco-pharmaceuticals/scenarios/identifying-authoritative-sources/overview)
    - [Defining the new data-driven systems architecture overview](/practices/coco-pharmaceuticals/scenarios/defining-new-systems-architecture-overview/overview)
    - [Defining the key information supply chains](/practices/coco-pharmaceuticals/scenarios/defining-information-supply-chains/overview)
    - [Defining what is meant by continuous analytics](/practices/coco-pharmaceuticals/scenarios/defining-continuous-analytics/overview)
    - [Defining how employees can be data-enabled](/practices/coco-pharmaceuticals/scenarios/defining-data-enabled-employees/overview)
    - [Defining why a multi-faceted governance model is needed](/practices/coco-pharmaceuticals/scenarios/defining-multi-faceted-governance/overview)

* Defining common data definitions

    - [Defining the subject areas for data](/practices/coco-pharmaceuticals/scenarios/defining-subject-areas/overview)
    - [Defining a glossary](/practices/coco-pharmaceuticals/scenarios/defining-a-glossary/overview)

* [Building the multi-faceted governance team](/practices/coco-pharmaceuticals/scenarios/building-the-governance-team/overview)

* [Setting up the data governance program](/practices/coco-pharmaceuticals/scenarios/creating-data-governance-program/overview)

* [Investigating suspicious activity](/practices/coco-pharmaceuticals/scenarios/investigating-suspicious-activity/overview)

* [Receiving patient data from a hospital](/practices/coco-pharmaceuticals/scenarios/receiving-patient-data-from-a-hospital/overview)

* [Developing a new digital service using personal data](/practices/coco-pharmaceuticals/scenarios/new-clinical-trials-digital-service/overview)


--8<-- "snippets/abbr.md"
